AlzChem Group Balance Sheet Health
Financial Health criteria checks 6/6
AlzChem Group has a total shareholder equity of €163.6M and total debt of €57.5M, which brings its debt-to-equity ratio to 35.2%. Its total assets and total liabilities are €424.7M and €261.1M respectively. AlzChem Group's EBIT is €53.8M making its interest coverage ratio 13.4. It has cash and short-term investments of €11.9M.
Key information
35.2%
Debt to equity ratio
€57.50m
Debt
Interest coverage ratio | 13.4x |
Cash | €11.88m |
Equity | €163.56m |
Total liabilities | €261.12m |
Total assets | €424.68m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ACT's short term assets (€216.6M) exceed its short term liabilities (€82.6M).
Long Term Liabilities: ACT's short term assets (€216.6M) exceed its long term liabilities (€178.5M).
Debt to Equity History and Analysis
Debt Level: ACT's net debt to equity ratio (27.9%) is considered satisfactory.
Reducing Debt: ACT's debt to equity ratio has reduced from 84.7% to 35.2% over the past 5 years.
Debt Coverage: ACT's debt is well covered by operating cash flow (126.4%).
Interest Coverage: ACT's interest payments on its debt are well covered by EBIT (13.4x coverage).